Conatus Pharmaceuticals, Inc. (CNAT)


Stock Price Forecast

May 26, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Conatus Pharmaceuticals, Inc. chart...

About the Company

Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA.

Sector

Health Technology

Industry

Biotechnology

Employees

6

$15M

Total Revenue

6

Employees

$18M

Market Capitalization

-1.87

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $CNAT News

Conatus Pharmaceuticals (CNAT) Stock Soars on Positive Liver Drug Trial Results

8y ago, source: TheStreet.com

Conatus Pharmaceuticals (CNAT) stock is increasing in mid-morning trading on Wednesday after the company said a Phase 2 trial of its liver drug showed positive results. Conatus Pharmaceuticals ...

Todd Foley's Net Worth

17d ago, source: Benzinga.com

Todd Foley has an estimated net worth of $598 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., iTeos Therapeutics, Inc., TriVascular ...

MPM BIOVENTURES V, L.P.'s Net Worth

26d ago, source: Benzinga.com

Who is MPM BIOVENTURES V, L.P.? MPM BIOVENTURES V, L.P. has an estimated net worth of $192 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS ...

KPRX Kiora Pharmaceuticals, Inc.

5mon ago, source: Seeking Alpha

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead ...

Ionis Pharmaceuticals Inc IONS

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Alnylam Pharmaceuticals

5d ago, source: Forbes

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...

Amylyx Pharmaceuticals Inc AMLX

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Amneal Pharmaceuticals Inc.

4d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

When Will Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Turn A Profit?

1mon ago, source: Yahoo Finance

With the business potentially at an important milestone, we thought we'd take a closer look at Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) future prospects. Tarsus Pharmaceuticals, Inc., a ...

UPC Universe Pharmaceuticals INC

3d ago, source: Seeking Alpha

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers ...

Q4 2023 Ionis Pharmaceuticals Inc Earnings Call

26d ago, source: Yahoo Finance

Brett P. Monia; Founder, CEO & Director; Ionis Pharmaceuticals, Inc. D. Wade Walke; SVP of IR; Ionis Pharmaceuticals, Inc. Elizabeth L. Hougen; Executive VP of ...

Inovio Pharmaceuticals, Inc.

8mon ago, source: CNN

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...